- Home
- RPRX vs QSR Comparison
RPRX vs QSR Comparison
Compare RPRX & QSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | QSR |
|---|---|---|
| Founded | 1996 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4B | 25.2B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RPRX | QSR |
|---|---|---|
| Price | $66.77 | $74.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 28 |
| Target Price | $65.38 | ★ $85.32 |
| AVG Volume (30 Days) | ★ 3.0M | 2.6M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | 1.40% | ★ 3.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.71 | ★ 3.95 |
| Revenue | $2,378,193,000.00 | ★ $9,434,000,000.00 |
| Revenue This Year | $47.40 | $4.29 |
| Revenue Next Year | $9.10 | $0.40 |
| P/E Ratio | $94.74 | ★ $18.39 |
| Revenue Growth | 5.06 | ★ 12.23 |
| 52 Week Low | $36.03 | $65.28 |
| 52 Week High | $67.71 | $81.96 |
Technical Indicators
Market Signals| Indicator | RPRX | QSR |
|---|---|---|
| Relative Strength Index (RSI) | 73.14 | 54.27 |
| Support Level | $55.48 | $71.21 |
| Resistance Level | N/A | $75.92 |
| Average True Range (ATR) | 1.32 | 1.73 |
| MACD | 0.67 | 0.09 |
| Stochastic Oscillator | 90.98 | 66.73 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About QSR Restaurant Brands International Inc.
Restaurant Brands generates about $47 billion in system sales across more than 33,000 restaurants in over 120 markets, making it one of the largest restaurant companies globally. Its banners include Burger King (7,025 stores), Tim Hortons (4,586), Popeyes (3,578), and Firehouse Subs (1,449), concentrated in the US and Canada; these brands also comprise 16,403 franchised international locations as of year-end 2025. Restaurant Brands primarily earns revenue from franchise and property fees, supply chain sales within the Tim Hortons segment, company-operated restaurants, and advertising royalties.